MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MDM2 promotes SUMO-2/3 modification of p53 to modulate transcriptional activity
Authors
Keywords
-
Journal
CELL CYCLE
Volume 10, Issue 18, Pages 3176-3188
Publisher
Informa UK Limited
Online
2011-10-06
DOI
10.4161/cc.10.18.17436
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Reduced transcriptional activity in the p53 pathway of senescent cells revealed by the MDM2 antagonist nutlin-3
- (2016) Baoying Huang et al. Aging-US
- The nucleolar SUMO-specific protease SMT3IP1/SENP3 attenuates Mdm2-mediated p53 ubiquitination and degradation
- (2011) Tamotsu Nishida et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Downregulation of ΔNp63α in keratinocytes by p14ARF-mediated SUMO-conjugation and degradation
- (2011) Maria Vivo et al. CELL CYCLE
- One Function—Multiple Mechanisms: The Manifold Activities of p53 as a Transcriptional Repressor
- (2011) Levin Böhlig et al. JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
- PKCζ mediates disturbed flow-induced endothelial apoptosis via p53 SUMOylation
- (2011) Kyung-Sun Heo et al. JOURNAL OF CELL BIOLOGY
- Mechanisms, regulation and consequences of protein SUMOylation
- (2010) Kevin A. Wilkinson et al. BIOCHEMICAL JOURNAL
- SUMO chains: polymeric signals: Figure 1
- (2010) Alfred C.O. Vertegaal BIOCHEMICAL SOCIETY TRANSACTIONS
- p53-Ubl fusions as models of ubiquitination, sumoylation and neddylation of p53
- (2010) Stephanie A. Carter et al. CELL CYCLE
- Arf-induced turnover of the nucleolar nucleophosmin-associated SUMO-2/3 protease Senp3
- (2010) Mei-Ling Kuo et al. CELL CYCLE
- Nucleostemin
- (2010) Dorothy Lo et al. CELL CYCLE
- Mechanism of p53 stabilization by ATM after DNA damage
- (2010) Qian Cheng et al. CELL CYCLE
- Functional mimicry of the acetylated C-terminal tail of p53 by a SUMO-1 acetylated domain, SAD
- (2010) Amrita Cheema et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Adenovirus E1B 55-Kilodalton Protein Is a p53-SUMO1 E3 Ligase That Represses p53 and Stimulates Its Nuclear Export through Interactions with Promyelocytic Leukemia Nuclear Bodies
- (2010) M. A. Pennella et al. JOURNAL OF VIROLOGY
- SUMO E3 ligase activity of TRIM proteins
- (2010) Y Chu et al. ONCOGENE
- NUB1 promotes cytoplasmic localization of p53 through cooperation of the NEDD8 and ubiquitin pathways
- (2010) G Liu et al. ONCOGENE
- SUMO association with repressor complexes, emerging routes for transcriptional control
- (2009) Mario Garcia-Dominguez et al. Biochimica et Biophysica Acta-Gene Regulatory Mechanisms
- Blinded by the Light: The Growing Complexity of p53
- (2009) Karen H. Vousden et al. CELL
- Mutant p53 Drives Invasion by Promoting Integrin Recycling
- (2009) Patricia A.J. Muller et al. CELL
- Small ubiquitin-related modifier paralogs are indispensable but functionally redundant during early development of zebrafish
- (2009) Hao Yuan et al. CELL RESEARCH
- Regulation of p53 family members by the ubiquitin-like SUMO system
- (2009) Per Stehmeier et al. DNA REPAIR
- Crosstalk between sumoylation and acetylation regulates p53-dependent chromatin transcription and DNA binding
- (2009) Shwu-Yuan Wu et al. EMBO JOURNAL
- Kaposi's Sarcoma-associated Herpesvirus (KSHV) Encodes a SUMO E3 ligase That Is SIM-dependent and SUMO-2/3-specific
- (2009) Pei-Ching Chang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SUMO under stress: Figure 1
- (2008) Denis Tempé et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Modification ofDrosophilap53 by SUMO Modulates Its Transactivation and Pro-apoptotic Functions
- (2008) Federico Mauri et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Targeting tumor cells expressing p53 with a water-soluble inhibitor of Hdm2
- (2008) J. Kitagaki et al. MOLECULAR CANCER THERAPEUTICS
- The Fast-Growing Business of SUMO Chains
- (2008) Helle D. Ulrich MOLECULAR CELL
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started